42 results
424B3
ZVRA
Zevra Therapeutics Inc
10 Oct 23
Prospectus supplement
5:07pm
in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings … and related penalties under the False Claims Act and result in reputational and economic harm.
Physicians may prescribe FDA-approved drugs for uses
S-4/A
ZVRA
Zevra Therapeutics Inc
6 Oct 23
Registration of securities issued in business combination transactions (amended)
4:06pm
, reputational harm, diminished profits and future earnings and curtailment or restructuring of Acer’s operations, any of which could adversely affect Acer’s … letters, corrective advertising, injunction, violation and related penalties under the False Claims Act and result in reputational and economic harm
S-4
ZVRA
Zevra Therapeutics Inc
28 Sep 23
Registration of securities issued in business combination transactions
9:25pm
in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings … , warning letters, corrective advertising, injunction, violation and related penalties under the False Claims Act and result in reputational
424B3
f8jkh
10 Nov 21
Prospectus supplement
5:19pm
424B3
0uvzywadr05x4
16 Aug 21
Prospectus supplement
12:00am
424B3
vdsxloi
13 May 21
Prospectus supplement
9:11pm
424B3
z42hlspbm2xypg6m
11 Mar 21
Prospectus supplement
9:56pm
424B4
5nuo4g95zjfieef
8 Jan 21
Prospectus supplement with pricing info
9:38pm